Cite
Stroopinsky D, Rajabi H, Nahas M, et al. MUC1-C drives myeloid leukaemogenesis and resistance to treatment by a survivin-mediated mechanism. J Cell Mol Med. 2018;doi: 10.1111/jcmm.13662.
Stroopinsky, D., Rajabi, H., Nahas, M., Rosenblatt, J., Rahimian, M., Pyzer, A., Tagde, A., Kharbanda, A., Jain, S., Kufe, T., Leaf, R. K., Anastasiadou, E., Bar-Natan, M., Orr, S., Coll, M. D., Palmer, K., Ephraim, A., Cole, L., Washington, A., Kufe, D., & Avigan, D. (2018). MUC1-C drives myeloid leukaemogenesis and resistance to treatment by a survivin-mediated mechanism. Journal of cellular and molecular medicine, . https://doi.org/10.1111/jcmm.13662
Stroopinsky, Dina, et al. "MUC1-C drives myeloid leukaemogenesis and resistance to treatment by a survivin-mediated mechanism." Journal of cellular and molecular medicine vol. (2018). doi: https://doi.org/10.1111/jcmm.13662
Stroopinsky D, Rajabi H, Nahas M, Rosenblatt J, Rahimian M, Pyzer A, Tagde A, Kharbanda A, Jain S, Kufe T, Leaf RK, Anastasiadou E, Bar-Natan M, Orr S, Coll MD, Palmer K, Ephraim A, Cole L, Washington A, Kufe D, Avigan D. MUC1-C drives myeloid leukaemogenesis and resistance to treatment by a survivin-mediated mechanism. J Cell Mol Med. 2018 May 15; doi: 10.1111/jcmm.13662. Epub 2018 May 15. PMID: 29761849; PMCID: PMC6050463.
Copy
Download .nbib